Global Health Priority Box
A MMV-IVCC compound sharing initiative facilitating research innovation by providing 240 compounds to accelerate the discovery of new insecticides and antimalarial drugs.
Justin McBeath
Justin joined IVCC as CEO in 2023. He is responsible for the development and delivery of IVCC’s strategy. He brings with him more than 25 years of experience working in…
Andrew Deyi Saibu
Andrew’s key responsibilities are to provide coordination, oversight and day-to-day management of country-level engagement for partnerships. He works on NgenIRS and the New Nets Project. He is also responsible for…
Dr Christen Fornadel
Christen provides technical leadership, coordination, and oversight in support of IVCC products from development to launch, including monitoring and evaluation of novel vector control tools and the design and implementation…
Dr Kath Gleave
In her role as Field Entomologist, Kath is responsible for supporting technical activities in IVCCs core insecticide-treated nets (ITNs) and indoor residual spraying (IRS) pillars. She supports laboratory and field…
Dr Renaud Govoetchan
In the role of Field Entomologist, Renaud oversees laboratory and field trials to support vector control product development projects with IVCC partners. Within the technical team, he works closely with…
Dr Janneke Snetselaar
In her role as Senior Technical Manager, Janneke is responsible for managing laboratory and field trials designed to support product development projects. She works closely with IVCC’s network of collaborating…
Dr Natalie Lissenden
Natalie (She/Her) is a medical entomologist and technical manager at IVCC. Specifically, her work focuses on Anophelesmosquito behaviour, with a focus on new tools for malaria vector control. She is…
IVCC-IHI data analysis workshop
Collaborating with the Ifakara Health Institute to enhance data analysis skills, equipping researchers with the tools to advance malaria vector control.
Modern Slavery Statement
LSTM (Group) – Modern Slavery Act Transparency Statement 2024 This is Liverpool School of Tropical Medicine (LSTM) Group’s statement for the financial year 2023-24. Introduction from the Director of LSTM…